List of Supplementary Protection Certificates
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Biologic Drug Supplementary Protection Certificates
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2470526 | C201930019 | Spain | PRODUCT NAME: ENCORAFENIB O UNA SAL O UN SOLVATO FARMACEUTICAMENTE ACEPTABLE DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/18/1314; DATE OF AUTHORISATION: 20180920; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/18/1314; DATE OF FIRST AUTHORISATION IN EEA: 20180920 | See Plans and Pricing |
European Patent Office | 2474557 | LUC00170 | Luxembourg | PRODUCT NAME: POLATUZUMAB VEDOTIN; AUTHORISATION NUMBER AND DATE: EU/1/19/1388 20200120 | See Plans and Pricing |
European Patent Office | 2041177 | CR 2017 00061 | Denmark | PRODUCT NAME: SARILUMAB; REG. NO/DATE: EU/1/17/1196/001-8 20170627 | See Plans and Pricing |
European Patent Office | 1713823 | 1490064-1 | Sweden | PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516 | See Plans and Pricing |
>Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |